NCT04543409 A Study of Benralizumab in Patients With Eosinophilic Esophagitis Status TERMINATED Phase PHASE3
NCT04543110 Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC Status UNKNOWN Phase PHASE2
NCT04541433 A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT04541212 Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04538742 A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04536402 Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice Status COMPLETED Phase N/A
NCT04532918 Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04532645 Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK Status COMPLETED Phase N/A
NCT04529772 A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04529564 Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA) Status COMPLETED Phase N/A
NCT04525183 REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue Status COMPLETED Phase NA
NCT04522544 Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC Status RECRUITING Phase PHASE2
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults Status COMPLETED Phase PHASE3
NCT04515849 A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT04514458 Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure Status COMPLETED Phase NA
NCT04507256 AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 Status COMPLETED Phase PHASE1
NCT04504669 First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours Status COMPLETED Phase PHASE1